¼¼Æ÷ ºÐ¸® ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø : ¼¼Æ÷ À¯Çüº°, ¿ëµµº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Cell Isolation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Cell Type, By Application, By Region and Competition, 2020-2030F
¼¼Æ÷ ºÐ¸® ¼¼°è ½ÃÀåÀº 2024³â¿¡ 34¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2030³â¿¡´Â 47¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇϰí, CAGR 5.62%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼Æ÷ºÐ¸®(È¥ÇÕµÈ Áý´Ü¿¡¼ ƯÁ¤ ¼¼Æ÷ À¯ÇüÀ» ºÐ¸®ÇÏ´Â °úÁ¤)´Â Àç»ýÀÇÇÐ, ¾Ï ¿¬±¸, ¸é¿ªÄ¡·á, Áٱ⼼Æ÷ »ý¹°ÇÐ µîÀÇ ºÐ¾ß¿¡¼ ±âÃʰ¡ µÇ°í ÀÖ½À´Ï´Ù. »ý¸í°úÇÐ ºÐ¾ßÀÇ ¹ßÀü¿¡ µû¶ó °í¼øµµ, »ýÁ¸ °¡´ÉÇÑ ¼¼Æ÷¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¸é¼ ¼¼Æ÷ ºÐ¸®ÀÇ Á¤È®¼º, È®À强, È¿À²¼ºÀ» ³ôÀÌ´Â ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå °³¿ä |
¿¹Ãø ±â°£ |
2026-2030³â |
½ÃÀå ±Ô¸ð : 2024³â |
34¾ï 7,000¸¸ ´Þ·¯ |
½ÃÀå ±Ô¸ð : 2030³â |
47¾ï 6,000¸¸ ´Þ·¯ |
CAGR : 2025-2030³â |
5.62% |
±Þ¼ºÀå ºÎ¹® |
Àΰ£ ¼¼Æ÷ |
ÃÖ´ë ½ÃÀå |
ºÏ¹Ì |
¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀº ¸ÂÃãÇü ÀÇ·áÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ¸ÂÃãÀÇ·á´Â Ç¥Àû Ä¡·áÁ¦ °³¹ßÀ» À§ÇØ È¯ÀÚ °íÀ¯ÀÇ ¼¼Æ÷¸¦ ºÐ¸®ÇÏ´Â °Í¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ä±¸´Â ¸é¿ª¿ä¹ýÀ̳ª ¼¼Æ÷ ±â¹Ý Ä¡·á°¡ Á¤È®ÇÑ ¼¼Æ÷ ¼±ÅÃÀÌ ÇÊ¿äÇÑ Á¾¾çÇп¡¼ ƯÈ÷ µÎµå·¯Áý´Ï´Ù. ³ôÀº ºñ¿ë°ú ±â¼úÀû À庮, ƯÈ÷ Èñ±ÍÇÏ°í ¹Î°¨ÇÑ ¼¼Æ÷¸¦ ºÐ¸®ÇÏ´Â µ¥ ÀÖ¾î ³ôÀº ºñ¿ë°ú ±â¼úÀû À庮ÀÌ ¹®Á¦ÀÌÁö¸¸, ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÅÈï ½ÃÀåÀº ÀÇ·á ÀÎÇÁ¶ó, ¿¬±¸ ¿ª·®, ÀǾàǰ Á¦Á¶¿¡ ´ëÇÑ ÅõÀÚ È®´ë¿¡ ÈûÀÔ¾î »õ·Î¿î ¼ºÀå ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù.
ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀÎ
ÇコÄÉ¾î »ê¾÷ÀÇ ¼ºÀå
ÁÖ¿ä ½ÃÀå °úÁ¦
¼¼Æ÷ ºÐ¸® ±â¼úÀÇ ³ôÀº ºñ¿ë
ÁÖ¿ä ½ÃÀå µ¿Çâ
¼¼Æ÷ ±â¹Ý Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
¸ñÂ÷
Á¦1Àå °³¿ä
Á¦2Àå Á¶»ç ¹æ¹ý
Á¦3Àå ÁÖ¿ä ¿ä¾à
Á¦4Àå COVID-19°¡ ¼¼°èÀÇ ¼¼Æ÷ ºÐ¸® ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
Á¦5Àå ¼¼°èÀÇ ¼¼Æ÷ ºÐ¸® ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
- ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
- ¼¼Æ÷ Á¾·ùº°(Àΰ£ ¼¼Æ÷, µ¿¹° ¼¼Æ÷)
- ¿ëµµº°(»ýüºÐÀÚ ºÐ¸®, ¾Ï Á¶»ç, Áٱ⼼Æ÷ Á¶»ç, ü¿ÜÁø´Ü, ±âŸ)
- Áö¿ªº°
- ±â¾÷º°(2024)
- ½ÃÀå ¸Ê
Á¦6Àå ºÏ¹ÌÀÇ ¼¼Æ÷ ºÐ¸® ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
- ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
- ºÏ¹Ì : ±¹°¡º° ºÐ¼®
Á¦7Àå À¯·´ÀÇ ¼¼Æ÷ ºÐ¸® ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
- ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
- À¯·´ : ±¹°¡º° ºÐ¼®
- ÇÁ¶û½º
- µ¶ÀÏ
- ¿µ±¹
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¼¼Æ÷ ºÐ¸® ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
- ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º° ºÐ¼®
Á¦9Àå ³²¹ÌÀÇ ¼¼Æ÷ ºÐ¸® ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
- ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
- ³²¹Ì : ±¹°¡º° ºÐ¼®
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- ÄÝ·Òºñ¾Æ
Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¼¼Æ÷ ºÐ¸® ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
- ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° ºÐ¼®
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
Á¦11Àå ½ÃÀå ¿ªÇÐ
Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü
- ÀμöÇÕº´
- Á¦Ç° Ãâ½Ã
- ÃÖ±Ù µ¿Çâ
Á¦13Àå È¥¶õ : ºÐÀï, ÆÒµ¥¹Í, ¹«¿ªÀ庮
Á¦14Àå ¼¼°èÀÇ ¼¼Æ÷ ºÐ¸® ½ÃÀå : SWOT ºÐ¼®
Á¦15Àå Porter's Five Forces ºÐ¼®
- ¾÷°è³» °æÀï
- ½Å±Ô Âü¿©ÀÇ °¡´É¼º
- °ø±Þ¾÷üÀÇ ´É·Â
- °í°´ÀÇ ´É·Â
- ´ëüǰÀÇ À§Çù
Á¦16Àå °æÀï ±¸µµ
- Becton, Dickinson & Company
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Terumo Corporation
- PluriSelect Life Science UG & Co. KG
- Danaher Corporation
- STEMCELL Technologies Inc.
- Corning Inc.
- Akadeum Life Sciences Inc.
Á¦17Àå Àü·«Àû Á¦¾È
Á¦18Àå Á¶»ç ȸ»ç ¼Ò°³ ¹× ¸éÃ¥»çÇ×
ksm
The Global Cell Isolation Market was valued at USD 3.47 billion in 2024 and is projected to reach USD 4.76 billion by 2030, expanding at a CAGR of 5.62%. Cell isolation-the process of separating specific cell types from a mixed population-is fundamental in fields such as regenerative medicine, cancer research, immunotherapy, and stem cell biology. As the life sciences sector advances, the demand for high-purity and viable cells is driving increased investment in technologies that offer enhanced precision, scalability, and efficiency in cell separation.
Market Overview |
Forecast Period | 2026-2030 |
Market Size 2024 | USD 3.47 Billion |
Market Size 2030 | USD 4.76 Billion |
CAGR 2025-2030 | 5.62% |
Fastest Growing Segment | Human Cells |
Largest Market | North America |
A primary growth driver is the growing adoption of personalized medicine, which depends on isolating patient-specific cells for the development of targeted therapies. This need is particularly prominent in oncology, where immunotherapies and cell-based treatments require accurate cell selection. While high costs and technical barriers pose challenges-especially in isolating rare or delicate cell types-emerging markets in the Asia-Pacific region are creating new opportunities for expansion, supported by growing investments in healthcare infrastructure, research capabilities, and pharmaceutical manufacturing.
Key Market Drivers
Growth in Healthcare Industry
The expansion of the global healthcare industry is a central factor driving the growth of the cell isolation market. With annual revenues exceeding USD 4 trillion, healthcare is supported by key sectors such as pharmaceuticals and biotechnology, contributing nearly USD 850 billion, and medical technology and diagnostics, which account for over USD 400 billion. This industry growth-especially in emerging economies-is accelerating the adoption of advanced diagnostic and therapeutic tools, including cell-based solutions.
As hospitals, laboratories, and pharmaceutical firms increasingly invest in regenerative therapies and precision medicine, the demand for scalable and reliable cell isolation techniques is rising. Additionally, the increasing global prevalence of chronic illnesses, including cancer and autoimmune diseases, has intensified the need for targeted therapies. In 2021, noncommunicable diseases were responsible for over 43 million deaths globally, with the majority occurring prematurely in low- and middle-income countries-reinforcing the importance of cell-based technologies for future treatment protocols.
Key Market Challenges
High Cost of Cell Isolation Technologies
The high cost associated with cell isolation technologies continues to be a major limitation for broader adoption, particularly in resource-limited settings. Systems like fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting (MACS) require sophisticated instruments, proprietary reagents, and specialized personnel, all contributing to significant operational costs.
These expenses present a substantial barrier for smaller laboratories, academic institutions, and biotech startups. Moreover, ongoing costs-such as maintenance, consumables, and technical support-can hinder the full utilization of cell isolation tools, especially in developing countries where funding and access to infrastructure are limited.
Key Market Trends
Increased Demand for Cell-Based Therapies
A key trend influencing the cell isolation market is the rising demand for cell-based therapies. By 2035, treatments such as CAR-T, TCR, and TIL therapies are expected to make up over 45% of clinical demand for cell therapy products. These therapies are gaining traction for their ability to address a wide array of diseases, including cancer, autoimmune conditions, and degenerative disorders.
This shift toward cell-based interventions is driving the need for robust isolation technologies that can reliably deliver high-quality, contamination-free, and functional cells. As the industry focuses more on precision medicine, the development and clinical use of cell therapies require advanced systems capable of delivering consistent and reproducible results in complex workflows.
Key Market Players
- Becton, Dickinson & Company
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Terumo Corporation
- PluriSelect Life Science UG & Co. KG
- Danaher Corporation
- STEMCELL Technologies Inc.
- Corning Inc.
- Akadeum Life Sciences Inc.
Report Scope
In this report, the Global Cell Isolation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Cell Isolation Market, By Cell Type:
Cell Isolation Market, By Application:
- Biomolecule Isolation
- Cancer Research
- Stem Cell Research
- In Vitro Diagnostics
- Others
Cell Isolation Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Cell Isolation Market.
Available Customizations
Global Cell Isolation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Cell Isolation Market
5. Global Cell Isolation Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Cell Type (Human Cells, Animal Cells)
- 5.2.2. By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In Vitro Diagnostics, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
- 5.3. Market Map
6. North America Cell Isolation Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Cell Type
- 6.2.2. By Application
- 6.2.3. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Cell Isolation Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Cell Type
- 6.3.1.2.2. By Application
- 6.3.2. Mexico Cell Isolation Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Cell Type
- 6.3.2.2.2. By Application
- 6.3.3. Canada Cell Isolation Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Cell Type
- 6.3.3.2.2. By Application
7. Europe Cell Isolation Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Cell Type
- 7.2.2. By Application
- 7.2.3. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. France Cell Isolation Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Cell Type
- 7.3.1.2.2. By Application
- 7.3.2. Germany Cell Isolation Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Cell Type
- 7.3.2.2.2. By Application
- 7.3.3. United Kingdom Cell Isolation Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Cell Type
- 7.3.3.2.2. By Application
- 7.3.4. Italy Cell Isolation Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Cell Type
- 7.3.4.2.2. By Application
- 7.3.5. Spain Cell Isolation Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Cell Type
- 7.3.5.2.2. By Application
8. Asia Pacific Cell Isolation Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Cell Type
- 8.2.2. By Application
- 8.2.3. By Country
- 8.3. Asia Pacific: Country Analysis
- 8.3.1. China Cell Isolation Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Cell Type
- 8.3.1.2.2. By Application
- 8.3.2. India Cell Isolation Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Cell Type
- 8.3.2.2.2. By Application
- 8.3.3. South Korea Cell Isolation Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Cell Type
- 8.3.3.2.2. By Application
- 8.3.4. Japan Cell Isolation Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Cell Type
- 8.3.4.2.2. By Application
- 8.3.5. Australia Cell Isolation Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Cell Type
- 8.3.5.2.2. By Application
9. South America Cell Isolation Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Cell Type
- 9.2.2. By Application
- 9.2.3. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Cell Isolation Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Cell Type
- 9.3.1.2.2. By Application
- 9.3.2. Argentina Cell Isolation Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Cell Type
- 9.3.2.2.2. By Application
- 9.3.3. Colombia Cell Isolation Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Cell Type
- 9.3.3.2.2. By Application
10. Middle East and Africa Cell Isolation Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Cell Type
- 10.2.2. By Application
- 10.2.3. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Cell Isolation Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Cell Type
- 10.3.1.2.2. By Application
- 10.3.2. Saudi Arabia Cell Isolation Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Cell Type
- 10.3.2.2.2. By Application
- 10.3.3. UAE Cell Isolation Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Cell Type
- 10.3.3.2.2. By Application
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Disruptions : Conflicts, Pandemics and Trade Barriers
14. Global Cell Isolation Market: SWOT Analysis
15. Porters Five Forces Analysis
- 15.1. Competition in the Industry
- 15.2. Potential of New Entrants
- 15.3. Power of Suppliers
- 15.4. Power of Customers
- 15.5. Threat of Substitute Products
16. Competitive Landscape
- 16.1. Becton, Dickinson & Company
- 16.1.1. Business Overview
- 16.1.2. Company Snapshot
- 16.1.3. Products & Services
- 16.1.4. Financials (As Reported)
- 16.1.5. Recent Developments
- 16.1.6. Key Personnel Details
- 16.1.7. SWOT Analysis
- 16.2. Merck KGaA
- 16.3. Thermo Fisher Scientific Inc.
- 16.4. Bio-Rad Laboratories Inc.
- 16.5. Terumo Corporation
- 16.6. PluriSelect Life Science UG & Co. KG
- 16.7. Danaher Corporation
- 16.8. STEMCELL Technologies Inc.
- 16.9. Corning Inc.
- 16.10. Akadeum Life Sciences Inc.
17. Strategic Recommendations
18. About Us & Disclaimer